AI-Powered test aims to match cancer patients with best drugs
NCT ID NCT07171554
Summary
This study is testing a new diagnostic tool called µCAN for people with advanced colorectal cancer that has spread. The test analyzes a small sample of a patient's tumor in a lab, using machine learning to screen how it reacts to different drugs. The goal is to give doctors a personalized report recommending which treatment might work best for that specific patient's cancer when standard therapies have failed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (MCRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Akershus University Hospital
Lørenskog, Akershus, 1478, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.